期刊文献+

药物诱导的自身免疫性肝炎研究进展 被引量:5

Research advances in drug-induced autoimmune hepatitis
原文传递
导出
摘要 药物诱导的自身免疫性肝炎是由药物诱发的自身免疫反应所介导的肝损伤,由于与特发性自身免疫性肝炎的临床特征相似,临床上鉴别诊断往往非常困难。深入了解药物诱导的自身免疫性肝炎的发生情况、发病机制、所涉及的相关药物、风险因素、临床和组织学特点等,有助于更好地正确诊断和治疗本病。 Drug induced autoimmune hepatitis (DIAIH) refers to the liver injury mediated by druginduced autoimmune reaction. Since it has similar clinical features as idiopathic autoimmune hepatitis, it is often difficult to make differential diagnosis in clinical practice. A deep understanding of the development, pathogenesis, related drugs, risk factors, and clinical and histological features of DIAIH helps with the correct diagnosis and treatment of DIAIH.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2016年第11期874-876,共3页 Chinese Journal of Hepatology
基金 “十二五”科技重大专项(2012ZX09303-001) 国家自然科学基金课题面上项目(81670524) 上海交通大学医学院多中心临床研究项目
关键词 肝炎 自身免疫性 肝炎 中毒性 进展 Hepatitis, Autoimmune Hepatitis, toxic Progress
  • 相关文献

参考文献24

  • 1Larson AM, Poison J, Fontana R J, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study[J]. Hepatology, 2005, 42(6): 1364-1372.
  • 2Manns MP, Obermayer-Straub P. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease[J]. Hepatology, 1997, 26(4): 1054-1066.
  • 3Liu ZX, Kaplowitz N. Immune-mediated drug-induced liver disease[J]. Clin Liver Dis, 2002, 6(3): 755-774.
  • 4Bjomsson E, Talwalkar J, Treeprasertsuk S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis[J]. Hepatology, 2010, 51 (6): 2040-2048. DOI: 10.1002/hep.23588.
  • 5Heurgue A, Bemard-Chabert B, Diebold M, et al. Drug-induced autoimmune hepatitis: a frequent disorder[J]. Gut, 2007, 56 (Suppl III): A271.
  • 6Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drag-induced liver injury[J]. Hepatology, 2011, 54(3): 931- 939. DOI: 10.1002/hep.24481.
  • 7Punthakee Z, ScuUy LJ, Guindi MM, et al. Liver fibrosis attributed to lipid lowering medications: two cases[J]. J Intern Med, 2001, 250(3): 249-254.
  • 8Pelli N, Setti M, Ceppa P, et al. Autoimmune hepatitis revealed by atorvastatin[J]. Eur J Gastroenterol Hepatol, 2003, 15(8): 921-924.
  • 9Yilmaz B, Roach EC, Koldu S. Infliximab leading to autoirnmune hepatitis: an increasingly recognized side effect[J]. Dig Dis Sci, 2014, 59(10): 2602-2603. DOI: 10.1007/s10620-014-3323-z.
  • 10Islam MS, Wright G, Tanner P, et al. A case of anastrazole-related drug-induced autoimmune hepatitis[J]. Clin J Gastroenterol, 2014, 7(5): 414-417. DOI: 10.1007/s12328-014-0512-4.

二级参考文献3

  • 1Hijikata M,Miyakawa H,Matsushita M,et al.CYPP2D6poly-morphism and the presence of anti-LKM-1in patients with chronic hepatitis C[].Biochemical and Biophysical Research Communications.2000
  • 2Siddiqui J,Raina D,Abraham J,et al.Autoimmune hepatitis induced by statins[].Gastroenterology.2005
  • 3Wolters LM,Van Buuren HR.Rosuvastatin-associated hepati-tis with autoimmune features[].European Journal of Gastroenterology and Hepatology.2005

共引文献2

同被引文献35

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部